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S U M M A R Y
We report the case of a 43-year-old man with a Mycoplasma hominis brain abscess occurring after a
cranial trauma, which was identiﬁed by matrix-assisted laser desorption/ionization time-of-ﬂight mass
spectrometry (MALDI-TOF MS). The presence of colonies on classic blood agar plates and the use of
MALDI-TOF MS, a valuable diagnostic tool that identiﬁed M. hominis due to its presence in the VITEK MS
database, allowed the rapid diagnosis of this infection.
 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-SA license (http://creativecommons.org/licenses/by-
nc-sa/3.0/).
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Mycobacterium hominis is a bacterium mostly involved in
genitourinary tract infections (cervicitis) and neonatal infections
(conjunctivitis). M. hominis infections outside the genitourinary
tract, such as central nervous (CNS) infections, are rare. In adults,
CNS infections due to M. hominis are very rare and only 13 cases of
brain abscesses have been reported to date.1–3 We report herein
the occurrence of an M. hominis brain abscess after a head trauma,
which was rapidly identiﬁed by matrix-assisted laser desorption/
ionization time-of-ﬂight mass spectrometry (MALDI-TOF MS;
VITEK MS, bioMe´rieux).
2. Case report
A 43-year-old man was admitted to the University Hospital of
Angers (day 1) for a cranial trauma. This patient had a history of
chronic alcoholism and transient ischemic attack with post-stroke
epilepsy. A neurological examination performed on admission
resulted in a Glasgow Coma Scale (GCS) score of 6. A cerebral
computed tomography (CT) scan identiﬁed a subdural and a left* Corresponding author. Tel.: +33 2 41 35 50 13; fax: +33 2 41 35 41 64.
E-mail address: makempf@chu-angers.fr (M. Kempf).
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license (http://creativecommons.org/licenses/by-nc-sa/3.0/).frontal hematoma. The hematomas were evacuated surgically and
an intracranial pressure sensor was set up.
From the time of his admission, the patient presented a
constant body temperature of 38.5 8C, which occasionally in-
creased to 39.5 8C. Peripheral blood cultures were sterile. The
patient quickly developed aspiration pneumonia, which was
treated with 6 g of amoxicillin–clavulanic acid administered
intravenously (IV) daily (days 4 to 6). No respiratory degradation
was observed and he was extubated on day 5. However, given the
persistence of fever, two samples of cerebrospinal ﬂuid (CSF) were
taken (on days 4 and 9) and antibiotic treatment was changed to
6 g of cefotaxime administered IV daily (days 6 to 14). The results
of CSF bacterial cultures were negative.
On day 8, the intracranial pressure sensor was removed and
sent to the laboratory of bacteriology, which is standard procedure
for such devices. One millilitre of water was added to the sample
and mixed. Then, culture was performed on sheep blood agar
(COLS+; Oxoid, Dardilly, France) in aerobic and anaerobic
conditions, and on chocolate agar (CHOCV; Oxoid) in air with 5%
CO2. After 5 days of incubation, small pinpoint colonies were
observed on the three agar plates. Gram staining showed no
bacteria. The colonies were identiﬁed by MALDI-TOF MS, which
revealed a 99.9% match with M. hominis. The identiﬁcation of
bacteria with MALDI-TOF MS is based on the determination of
the exact molecular masses of small proteins by measuring theciety for Infectious Diseases. This is an open access article under the CC BY-NC-SA
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protein mass spectrum, which is characteristic for each species. To
conﬁrm the result, 16S rDNA sequencing was performed both
directly on the sample and on the colonies. This identiﬁed M.
hominis in the intracranial pressure sensor, conﬁrming the results
of MALDI-TOF MS. In light of these results, the decision was made
to carry out 16S rDNA sequencing on the CSF sample taken on day
9; the sample tested negative for bacterial DNA. At this time, the M.
hominis present in the cranial pressure sensor was not considered
as pathogenic.
From day 10 to day 14, the patient experienced an episode of
delirium tremens. Following this, the patient drifted in and out of
consciousness, with a GCS score varying from 13 to 14. No cerebral
motor deﬁcit was observed. The patient continued to be febrile, but
blood cultures taken on day 15 gave negative results. Moreover,
bacteriological cultures of a new sample of CSF gave negative
results after 7 days of incubation.
On day 16, cerebral CT showed an empyema in the left brain
hemisphere with brain herniation (Figure 1). This empyema was
surgically drained and sent to the bacteriology laboratory.
Empiric antibiotherapy was initiated, consisting of 6 g of
meropenem, 4 g of vancomycin, and 16 g of fosfomycin all
administered IV daily. The patient’s level of consciousness
improved after surgical evacuation of the brain abscess. Gram
staining performed on the brain abscess was negative. RoutineFigure 1. Cerebral computed tomography revealing left frontal and right parieto-occipdiagnostic techniques described above were used. After 4 days of
incubation, small colonies were observed. MALDI-TOF MS
identiﬁed M. hominis (99.9%), which was conﬁrmed by 16S
rDNA sequencing.
Antibiotic susceptibility testing with the Etest (levoﬂoxacin)
and the disc diffusion method (doxycycline) was performed as
follows: 200 ml of abscess was mixed with 1 ml of water and
inoculated by inundation onto sheep blood agar. The agar plates
were incubated for 3 days at 36 8C in aerobic conditions. A minimal
inhibitory concentration of 0.06 mg/l was obtained for levoﬂoxacin
and a diameter of 25 mm for doxycycline. Staphylococcus aureus
breakpoints were used because no European Committee on
Antibiotic Susceptibility Testing (EUCAST) breakpoints have been
deﬁned for M. hominis (http://www.eucast.org/clinical_break-
points/). In this case the M. hominis was considered susceptible
to levoﬂoxacin and doxycycline.
On day 20, 1 g of levoﬂoxacin IV daily was added to the regimen
of meropenem and vancomycin. Treatment with vancomycin and
meropenem was stopped on day 22 and day 24, respectively,
following deﬁnitive bacteriological results showing no other
bacterium in the cerebral abscess. On day 22, the patient’s body
temperature decreased, but a low-grade fever persisted; therefore,
400 mg of oral doxycycline daily was added to the treatment
regimen on day 29. The patient rapidly became apyretic and was
discharged from hospital.ital abscesses. These lesions are accompanied by enhancement in the meninges.
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In this case, M. hominis was identiﬁed in the intracranial
pressure sensor and in brain abscess liquid, whereas the bacterium
was absent from the CSF.
In most of the cases of M. hominis brain abscess described in the
literature, patients have presented co-morbidities such as a head
trauma or neurosurgery.1 Three sources for an M. hominis cerebral
abscess can be suggested: direct contamination during trauma,
direct contamination during surgery, or seeding of the cerebral site
secondary to bacteraemia due to genitourinary manipulation.
Indeed, urinary tract catheterization has been associated with
Mycoplasma bacteraemia leading to the seeding of brain-damaged
tissues in some cases.4 In our case, the patient was exposed to the
three hypothetical sources of contamination. The head trauma was
cured by a neurosurgical intervention, but he also underwent
urinary catheterization and the genitourinary tract tested positive
for M. hominis. Therefore, we were unable to deﬁnitively identify
the source of infection.
The identiﬁcation of M. hominis infections is often challenging
due to the slow growth of the colonies and the absence of cell wall,
which gives a negative result on Gram staining. In contrast to other
cases,1 the M. hominis culture in the present case was obtained on
agar plates used routinely in the laboratory; bacteriologists must
be alerted to this possibility. In most reports of cerebral infections,
M. hominis has been identiﬁed after 16S rDNA sequencing.5 Here
we found MALDI-TOF MS to be very useful for the rapid
identiﬁcation of M. hominis. This has also been shown previously
by Pereyre et al. who successfully applied this technique for the
identiﬁcation of Mycoplasma spp, including M. hominis isolates.6 In
our case of M. hominis CNS infection, MALDI-TOF MS was a reliable
tool and the use of 16S rDNA sequencing could have been avoided.In the present case, a low-grade fever persisted with
levoﬂoxacin alone and the patient quickly became apyretic when
doxycycline was added. The association of tetracycline and a
ﬂuoroquinolone was necessary to improve the patient’s condition,
probably because of the poor penetration of one antibiotic across
the blood–brain barrier.
This case emphasizes the pathogenic potential of M. hominis in
brain infections. M. hominis brain abscesses can be cured by surgical
drainage associated with appropriate antibiotic treatment. A
greater awareness of the possible presence of M. hominis in such
infections and the easier identiﬁcation of this bacterium with
MALDI-TOF MS, a well-established technique in bacteriology
laboratories, may help elucidate its role in such infectious processes.
Conﬂict of interest: The authors declare no conﬂict of interest.
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